Cannabis and risk of psychosis

Cannabis and risk of psychosis

Bibliographic Details
Main Authors:	M Drewe, J Drewe
Format:	Article
Language:	English
Published:	SMW supporting association (Trägerverein Swiss Medical Weekly SMW) 2004-11-01
Series:	Swiss Medical Weekly
Subjects:	Schizophrenia Psychosis Cannabis
Online Access:	https://www.smw.ch/index.php/smw/article/view/435

Similar Items

Cannabis-induced psychosis or Cannabis-associated psychosis: Diagnostically no clear winner
by: Srinivas Rajkumar, et al.
Published: (2016-01-01)

Cannabis-induced psychosis masquerading schizophrenia or vice-versa? A diagnostic dilemma
by: Rachit Sharma, et al.
Published: (2021-01-01)

Sociodemographic and clinical profile of cannabis-induced psychosis: A comparative study
by: Debasish Padhi, et al.
Published: (2021-01-01)

Early onset of cannabis use and violent behavior in psychosis
by: Valerie Moulin, et al.
Published: (2020-01-01)

Pathways from cannabis to psychosis: a review of the evidence
by: Jonathan K Burns
Published: (2013-10-01)

Gone to Pot - A Review of the Association between Cannabis and Psychosis
by: Rajiv eRadhakrishnan, et al.
Published: (2014-05-01)

Lifetime Cannabis Use Is Not Associated With Negative Beliefs About Medication in Patients With First Treatment Psychosis
by: Priyanthi B. Gjerde, et al.
Published: (2022-03-01)

First vs. multiple cannabis-induced psychotic episodes: Is inpatient treatment any different?
by: F. Andrade, et al.
Published: (2021-04-01)

Acceptance of pharmaceutical cannabis substitution by cannabis using patients with schizophrenia
by: Jan van Amsterdam, et al.
Published: (2018-09-01)

Cannabidiol versus risperidone for treatment of recent-onset psychosis with comorbid cannabis use: study protocol for a randomized controlled clinical trial
by: Jesper Østrup Rasmussen, et al.
Published: (2021-08-01)

Relationship between the Polymorphism of the AKT1 Gene and the Consumption of Cannabis in the Appearance of Psychosis
by: Mónica López-Martín, et al.
Published: (2022-10-01)

Development and initial validation of the cannabis-related psychosis risk literacy scale (CPRL): a multinational psychometric study
by: Feten Fekih-Romdhane, et al.
Published: (2024-04-01)

The Impact of Cannabis Abuse on Psychotic Symptoms and Their Severity among Cannabis Associated Psychosis Subjects: An Indian Experience
by: Ramchandra Lamba, et al.
Published: (2021-03-01)

Drug-induced psychosis: how to avoid star gazing in schizophrenia research by looking at more obvious sources of light
by: Alessandra Paparelli, et al.
Published: (2011-01-01)

Cannabis use and cognition in schizophrenia
by: Else-Marie Løberg, et al.
Published: (2009-11-01)

Immune regulatory gene polymorphisms, frequent cannabis use, and psychosis: implications to Treg hypofunction
by: F. Corsi-Zuelli, et al.
Published: (2022-06-01)

Risk factors for the onset of dependence and chronic psychosis due to cannabis use: Survey of patients with cannabis‐related psychiatric disorders
by: Toshihiko Matsumoto, et al.
Published: (2020-12-01)

“I have no disease and weed just relaxes me!”: The therapeutic challenge in young patients with psychosis and cannabis abuse
by: P. Mota
Published: (2021-04-01)

Childhood trauma and substance use underlying psychosis: a systematic review
by: Esther Setién-Suero, et al.
Published: (2020-12-01)

A brain imaging study of dopamine receptor D2 availability in cannabis dependent users after recovery from cannabis-induced psychosis
by: Aviv M. Weinstein
Published: (2023-10-01)

Minimizing policy-biased appraisals of the evidence on cannabis and psychosis
by: Wayne Hall
Published: (2023-01-01)

Cannabis and schizophrenia: characterisation of a risk factor in a sample of Moroccan patients hospitalised for psychosis
by: El Hassan Ouanouche, et al.
Published: (2022-02-01)

The Link Between Cannabis Use and Violent Behavior in the Early Phase of Psychosis: The Potential Role of Impulsivity
by: Valerie Moulin, et al.
Published: (2022-03-01)

The effect of COVID-19 pandemic on admissions for cannabis-induced psychotic disorder
by: A. Elias De Sousa, et al.
Published: (2022-06-01)

Cannabis use and nonuse in patients with first-episode psychosis: A systematic review and meta-analysis of studies comparing neurocognitive functioning
by: Teresa Sánchez-Gutiérrez, et al.
Published: (2020-01-01)

Aberrant salience in cannabis-induced psychosis: a comparative study
by: Valerio Ricci, et al.
Published: (2024-01-01)

The Impact of THC and CBD in Schizophrenia: A Systematic Review
by: Saeed Ahmed, et al.
Published: (2021-07-01)

Cannabis use and abuse correlates in a homogenous South African schizophrenia population
by: Liezl Koen, et al.
Published: (2009-03-01)

Evaluation of the effect of schizotypy on cannabis use predictors
by: Fatma Eren, et al.
Published: (2017-10-01)

Evolution of substance use, neurological and psychiatric symptoms in schizophrenia and substance use disorder patients: a 12-week, pilot, case-control trial with quetiapine
by: Simon eZhornitsky, et al.
Published: (2011-05-01)

Migration: A risk factor for psychosis?
by: E. Spaho, et al.
Published: (2021-04-01)

Cannabis use and psychosis among patients hospitalized in psychiatric wards in Lebanon: a retrospective chart review
by: Pia Maria Ghanimé, et al.
Published: (2023-11-01)

Cognitive impairment in first psychotic episodes: The role of cannabis
by: S. Boi, et al.
Published: (2021-04-01)

Neurological soft signs in Tunisian patients with first-episode psychosis and relation with cannabis use
by: Ahmed Mhalla, et al.
Published: (2017-07-01)

Psychosis in Three Patients with Vitiligo
by: A KHeradmand, et al.
Published: (2009-07-01)

Relationship between cannabis use and schizophrenia
by: J.J. Vazquez Vazquez, et al.
Published: (2022-06-01)

Influence of migration on the thought process of individuals at ultra-high risk for psychosis
by: Arthur S. Nogueira, et al.
Published: (2020-08-01)

Resistance to depth inversion illusions: A biosignature of psychosis with potential utility for monitoring positive symptom emergence and remission in schizophrenia
by: Samantha I. Fradkin, et al.
Published: (2022-06-01)

Lifetime cannabis use and childhood trauma increase risk of psychosis in carriers of CNR1 genetic variants: findings from the STREAM study
by: Camila Marcelino Loureiro, et al.
Published: (2023-07-01)

Violence in persons with and without psychosis in the Czech Republic: risk and protective factors
by: Černý M, et al.
Published: (2018-10-01)